Sang Yi - Zimmer Biomet Group Pacific
| ZIM Stock | EUR 101.45 0.10 0.1% |
Insider
Sang Yi is Group Pacific of Zimmer Biomet Holdings
| Age | 61 |
| Phone | 574 267 6131 |
| Web | https://www.zimmerbiomet.com |
Sang Yi Latest Insider Activity
Tracking and analyzing the buying and selling activities of Sang Yi against Zimmer Biomet stock is an integral part of due diligence when investing in Zimmer Biomet. Sang Yi insider activity provides valuable insight into whether Zimmer Biomet is net buyers or sellers over its current business cycle. Note, Zimmer Biomet insiders must abide by specific rules, including filing SEC forms every time they buy or sell Zimmer Biomet'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Sang Yi over a year ago Sale by Sang Yi of 6097 shares of Zimmer Biomet | ||
Sang Yi over a year ago Exercise or conversion by Sang Yi of 2423 shares of Zimmer Biomet subject to Rule 16b-3 |
Zimmer Biomet Management Efficiency
The company has return on total asset (ROA) of 0.0371 % which means that it generated a profit of $0.0371 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0236 %, meaning that it generated $0.0236 on every $100 dollars invested by stockholders. Zimmer Biomet's management efficiency ratios could be used to measure how well Zimmer Biomet manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Bryan McCrory | Dave Busters Entertainment | N/A | |
| Pat Haggerty | Hollywood Bowl Group | N/A | |
| Steven Klohn | Dave Busters Entertainment | N/A | |
| Michel Guillemot | Ubisoft Entertainment SA | 64 | |
| John Parkes | Ubisoft Entertainment SA | 53 | |
| Darryl Lewis | Hollywood Bowl Group | N/A | |
| JeanBenot Roquette | Ubisoft Entertainment SA | N/A | |
| Colleen Harris | Ramsay Health Care | 54 | |
| Yves Guillemot | Ubisoft Entertainment SA | 63 | |
| Tony Wehner | Dave Busters Entertainment | 55 | |
| Ashley Zickefoose | Dave Busters Entertainment | N/A | |
| AC DSc | Ramsay Health Care | 70 | |
| LLB BECON | Ramsay Health Care | N/A | |
| Frdrick Duguet | Ubisoft Entertainment SA | N/A | |
| Randall Jones | Dave Busters Entertainment | N/A | |
| Martyn Roberts | Ramsay Health Care | 55 | |
| Adam Novickas | Ubisoft Entertainment SA | N/A | |
| Kah Hong | Ramsay Health Care | 50 | |
| Michael Quartieri | Dave Busters Entertainment | 55 | |
| Kelly Hibbins | Ramsay Health Care | N/A | |
| Joseph DeProspero | Dave Busters Entertainment | 48 | |
Management Performance
| Return On Equity | 0.0236 | |||
| Return On Asset | 0.0371 |
Zimmer Biomet Holdings Leadership Team
Elected by the shareholders, the Zimmer Biomet's board of directors comprises two types of representatives: Zimmer Biomet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zimmer. The board's role is to monitor Zimmer Biomet's management team and ensure that shareholders' interests are well served. Zimmer Biomet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zimmer Biomet's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chad Phipps, Gen VP | ||
| Ivan Tornos, Chief Officer | ||
| Sang Yi, Group Pacific | ||
| Paul Stellato, Controller VP | ||
| Keri Mattox, Chief Relations | ||
| Wilfred Zuilen, Middle Europe | ||
| Suketu Upadhyay, Ex CFO | ||
| Zeeshan Tariq, VP Officer | ||
| Bryan Hanson, Pres Chairman | ||
| Nitin MD, Technology Science |
Zimmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zimmer Biomet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0236 | |||
| Return On Asset | 0.0371 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 29.79 B | |||
| Shares Outstanding | 210.06 M | |||
| Shares Owned By Institutions | 90.95 % | |||
| Price To Earning | 10.60 X | |||
| Price To Book | 2.15 X | |||
| Price To Sales | 3.27 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zimmer Stock
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.